Cost-analysis of different management policies for patients with mild hepatitis A virus infection in Kazakhstan

Abdiaziz S. Yassin, Michael Favorov, Edmond Maes, Ramses Sadek, Aliya Jumagulova, Victor Merker, Tatiana Surdina, Terence Chorba

Research output: Contribution to journalArticle

Abstract

Objective: For patients with mild hepatitis A virus (HAV) infection, this study compared estimates of total costs associated with managing cases under a policy of mandatory hospitalization in the Republic of Kazakhstan and estimates of total costs associated with managing cases in outpatient settings. Costs were estimated both from the perspective of the Ministry of Health and from a broader societal perspective. Methods: Data were collected by using a standardized structured questionnaire. For cases of mild HAV infection, medical records were obtained from 200 patients managed by hospitalization and from 251 patients managed in an outpatient setting. Personal interviews were also conducted to collect information on productivity losses and out-of-pocket expenses. Results: Nationally, we estimated about 21,600 cases of mild HAV infection annually. The mean annual treatment costs in hospital for mild HAV infection was estimated at US$3.39 million (2001 US$) (95% confidence interval [CI] = [US$3.26 million - US$3.52 million]). The total annual mild HAV infection cost to the society, including direct medical and nonmedical costs and productivity losses due to 721,440 lost work days, was estimated at US$6.26 million (95% CI [US$6.05 million - US$6.47 million]). In sensitivity analyses, the total annual cost of mild HAV infection ranged from US$4.37 million to US$24.66 million. The survey results showed that a relatively minor change in the current policy of mandatory hospitalization could result in an estimated total annual savings of US$4.62 million (2001 US$) in Kazakhstan. Conclusion: Adoption of an outpatient management policy for cases of mild HAV infection would generate substantial cost savings to the Ministry of Health and society.

Original languageEnglish (US)
Article number4
JournalCost Effectiveness and Resource Allocation
Volume3
DOIs
StatePublished - May 12 2005

Fingerprint

Kazakhstan
Hepatitis A virus
Virus Diseases
Costs and Cost Analysis
Hospitalization
Outpatients
Confidence Intervals
Cost Savings
Health
Case Management
Health Expenditures
Health Care Costs
Medical Records
Interviews

ASJC Scopus subject areas

  • Health Policy

Cite this

Cost-analysis of different management policies for patients with mild hepatitis A virus infection in Kazakhstan. / Yassin, Abdiaziz S.; Favorov, Michael; Maes, Edmond; Sadek, Ramses; Jumagulova, Aliya; Merker, Victor; Surdina, Tatiana; Chorba, Terence.

In: Cost Effectiveness and Resource Allocation, Vol. 3, 4, 12.05.2005.

Research output: Contribution to journalArticle

Yassin, Abdiaziz S. ; Favorov, Michael ; Maes, Edmond ; Sadek, Ramses ; Jumagulova, Aliya ; Merker, Victor ; Surdina, Tatiana ; Chorba, Terence. / Cost-analysis of different management policies for patients with mild hepatitis A virus infection in Kazakhstan. In: Cost Effectiveness and Resource Allocation. 2005 ; Vol. 3.
@article{b42432f09cb04856886d097b2dba13a9,
title = "Cost-analysis of different management policies for patients with mild hepatitis A virus infection in Kazakhstan",
abstract = "Objective: For patients with mild hepatitis A virus (HAV) infection, this study compared estimates of total costs associated with managing cases under a policy of mandatory hospitalization in the Republic of Kazakhstan and estimates of total costs associated with managing cases in outpatient settings. Costs were estimated both from the perspective of the Ministry of Health and from a broader societal perspective. Methods: Data were collected by using a standardized structured questionnaire. For cases of mild HAV infection, medical records were obtained from 200 patients managed by hospitalization and from 251 patients managed in an outpatient setting. Personal interviews were also conducted to collect information on productivity losses and out-of-pocket expenses. Results: Nationally, we estimated about 21,600 cases of mild HAV infection annually. The mean annual treatment costs in hospital for mild HAV infection was estimated at US$3.39 million (2001 US$) (95{\%} confidence interval [CI] = [US$3.26 million - US$3.52 million]). The total annual mild HAV infection cost to the society, including direct medical and nonmedical costs and productivity losses due to 721,440 lost work days, was estimated at US$6.26 million (95{\%} CI [US$6.05 million - US$6.47 million]). In sensitivity analyses, the total annual cost of mild HAV infection ranged from US$4.37 million to US$24.66 million. The survey results showed that a relatively minor change in the current policy of mandatory hospitalization could result in an estimated total annual savings of US$4.62 million (2001 US$) in Kazakhstan. Conclusion: Adoption of an outpatient management policy for cases of mild HAV infection would generate substantial cost savings to the Ministry of Health and society.",
author = "Yassin, {Abdiaziz S.} and Michael Favorov and Edmond Maes and Ramses Sadek and Aliya Jumagulova and Victor Merker and Tatiana Surdina and Terence Chorba",
year = "2005",
month = "5",
day = "12",
doi = "10.1186/1478-7547-3-4",
language = "English (US)",
volume = "3",
journal = "Cost Effectiveness and Resource Allocation",
issn = "1478-7547",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Cost-analysis of different management policies for patients with mild hepatitis A virus infection in Kazakhstan

AU - Yassin, Abdiaziz S.

AU - Favorov, Michael

AU - Maes, Edmond

AU - Sadek, Ramses

AU - Jumagulova, Aliya

AU - Merker, Victor

AU - Surdina, Tatiana

AU - Chorba, Terence

PY - 2005/5/12

Y1 - 2005/5/12

N2 - Objective: For patients with mild hepatitis A virus (HAV) infection, this study compared estimates of total costs associated with managing cases under a policy of mandatory hospitalization in the Republic of Kazakhstan and estimates of total costs associated with managing cases in outpatient settings. Costs were estimated both from the perspective of the Ministry of Health and from a broader societal perspective. Methods: Data were collected by using a standardized structured questionnaire. For cases of mild HAV infection, medical records were obtained from 200 patients managed by hospitalization and from 251 patients managed in an outpatient setting. Personal interviews were also conducted to collect information on productivity losses and out-of-pocket expenses. Results: Nationally, we estimated about 21,600 cases of mild HAV infection annually. The mean annual treatment costs in hospital for mild HAV infection was estimated at US$3.39 million (2001 US$) (95% confidence interval [CI] = [US$3.26 million - US$3.52 million]). The total annual mild HAV infection cost to the society, including direct medical and nonmedical costs and productivity losses due to 721,440 lost work days, was estimated at US$6.26 million (95% CI [US$6.05 million - US$6.47 million]). In sensitivity analyses, the total annual cost of mild HAV infection ranged from US$4.37 million to US$24.66 million. The survey results showed that a relatively minor change in the current policy of mandatory hospitalization could result in an estimated total annual savings of US$4.62 million (2001 US$) in Kazakhstan. Conclusion: Adoption of an outpatient management policy for cases of mild HAV infection would generate substantial cost savings to the Ministry of Health and society.

AB - Objective: For patients with mild hepatitis A virus (HAV) infection, this study compared estimates of total costs associated with managing cases under a policy of mandatory hospitalization in the Republic of Kazakhstan and estimates of total costs associated with managing cases in outpatient settings. Costs were estimated both from the perspective of the Ministry of Health and from a broader societal perspective. Methods: Data were collected by using a standardized structured questionnaire. For cases of mild HAV infection, medical records were obtained from 200 patients managed by hospitalization and from 251 patients managed in an outpatient setting. Personal interviews were also conducted to collect information on productivity losses and out-of-pocket expenses. Results: Nationally, we estimated about 21,600 cases of mild HAV infection annually. The mean annual treatment costs in hospital for mild HAV infection was estimated at US$3.39 million (2001 US$) (95% confidence interval [CI] = [US$3.26 million - US$3.52 million]). The total annual mild HAV infection cost to the society, including direct medical and nonmedical costs and productivity losses due to 721,440 lost work days, was estimated at US$6.26 million (95% CI [US$6.05 million - US$6.47 million]). In sensitivity analyses, the total annual cost of mild HAV infection ranged from US$4.37 million to US$24.66 million. The survey results showed that a relatively minor change in the current policy of mandatory hospitalization could result in an estimated total annual savings of US$4.62 million (2001 US$) in Kazakhstan. Conclusion: Adoption of an outpatient management policy for cases of mild HAV infection would generate substantial cost savings to the Ministry of Health and society.

UR - http://www.scopus.com/inward/record.url?scp=27744486726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744486726&partnerID=8YFLogxK

U2 - 10.1186/1478-7547-3-4

DO - 10.1186/1478-7547-3-4

M3 - Article

AN - SCOPUS:27744486726

VL - 3

JO - Cost Effectiveness and Resource Allocation

JF - Cost Effectiveness and Resource Allocation

SN - 1478-7547

M1 - 4

ER -